Clinical Trial Update: Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating acetylcysteine for ventilator-associated pneumonia caused by carbapenem-resistant Klebsiella has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Acetylcysteine (Acetylcysteine)

Snippet

Sponsor: Tanta University | Conditions: Ventilator Associated Pneumonia ( VAP), Mechanical Ventilation | Phase 1 | Status: COMPLETED